Loading...
•
Dec 31, 2021
Seer Q4 2021 Earnings Report
Seer's Q4 2021 financial results were reported, demonstrating market progress with $3.1 million in revenue and advancements in commercial release of the Proteograph Product Suite.
Key Takeaways
Seer, Inc. reported a revenue of $3.1 million for Q4 2021, a significant increase compared to the previous year. The company's net loss for the quarter was $19.7 million. Broad commercial release of the Proteograph Product Suite commenced, with multiple orders pre-booked.
Revenue reached $3.1 million, driven by increased sales of the Proteograph Product Suite.
Gross profit for the quarter was $1.4 million, with a gross margin of 47%.
Operating expenses increased to $21.3 million due to higher employee compensation and costs related to being a publicly traded company.
Net loss was $19.7 million, compared to $12.9 million in the prior year period.
Revenue by Segment
Forward Guidance
Seer expects full year 2022 revenue to be in the range of $14.0 million to $16.0 million and plans to increase investments in commercial, operations, and research and development activities.
Positive Outlook
- Seer expects full year 2022 revenue to be in the range of $14.0 million to $16.0 million.
- The company plans to increase investments in its commercial activities.
- The company plans to increase investments in its operations activities.
- The company plans to increase investments in its research and development activities.
- Seer aims to drive long-term growth and value creation.
Challenges Ahead
- Increased investments in commercial, operations, and R&D activities may impact profitability in the short term.
- The company's outlook is subject to various risks and uncertainties.
- Actual results may differ materially from the company's expectations.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...